623 related articles for article (PubMed ID: 16504475)
1. Vascular smooth muscle migration and proliferation in response to lysophosphatidic acid (LPA) is mediated by LPA receptors coupling to Gq.
Kim J; Keys JR; Eckhart AD
Cell Signal; 2006 Oct; 18(10):1695-701. PubMed ID: 16504475
[TBL] [Abstract][Full Text] [Related]
2. The role of lysophosphatidic acid receptors in phenotypic modulation of vascular smooth muscle cells.
Zhou Z; Niu J; Zhang Z
Mol Biol Rep; 2010 Jul; 37(6):2675-86. PubMed ID: 19757175
[TBL] [Abstract][Full Text] [Related]
3. Receptor-mediated vascular smooth muscle migration induced by LPA involves p38 mitogen-activated protein kinase pathway activation.
Zhou ZB; Niu JP; Zhang ZJ
Int J Mol Sci; 2009 Jul; 10(7):3194-3208. PubMed ID: 19742132
[TBL] [Abstract][Full Text] [Related]
4. LPA
Dancs PT; Ruisanchez É; Balogh A; Panta CR; Miklós Z; Nüsing RM; Aoki J; Chun J; Offermanns S; Tigyi G; Benyó Z
FASEB J; 2017 Apr; 31(4):1547-1555. PubMed ID: 28069828
[TBL] [Abstract][Full Text] [Related]
5. Antidepressants activate the lysophosphatidic acid receptor LPA(1) to induce insulin-like growth factor-I receptor transactivation, stimulation of ERK1/2 signaling and cell proliferation in CHO-K1 fibroblasts.
Olianas MC; Dedoni S; Onali P
Biochem Pharmacol; 2015 Jun; 95(4):311-23. PubMed ID: 25888927
[TBL] [Abstract][Full Text] [Related]
6. Gq-coupled receptor agonists mediate cardiac hypertrophy via the vasculature.
Keys JR; Greene EA; Koch WJ; Eckhart AD
Hypertension; 2002 Nov; 40(5):660-6. PubMed ID: 12411459
[TBL] [Abstract][Full Text] [Related]
7. LPA1 receptors mediate stimulation, whereas LPA2 receptors mediate inhibition, of migration of pancreatic cancer cells in response to lysophosphatidic acid and malignant ascites.
Komachi M; Tomura H; Malchinkhuu E; Tobo M; Mogi C; Yamada T; Kimura T; Kuwabara A; Ohta H; Im DS; Kurose H; Takeyoshi I; Sato K; Okajima F
Carcinogenesis; 2009 Mar; 30(3):457-65. PubMed ID: 19129242
[TBL] [Abstract][Full Text] [Related]
8. Lysophosphatidic acid (LPA) enhances the metastatic potential of human colon carcinoma DLD1 cells through LPA1.
Shida D; Kitayama J; Yamaguchi H; Okaji Y; Tsuno NH; Watanabe T; Takuwa Y; Nagawa H
Cancer Res; 2003 Apr; 63(7):1706-11. PubMed ID: 12670925
[TBL] [Abstract][Full Text] [Related]
9. Role of lysophosphatidic acid in vascular smooth muscle cell proliferation.
Liu Y; Chen F; Ji L; Zhang L; Xu YJ; Dhalla NS
Can J Physiol Pharmacol; 2020 Feb; 98(2):103-110. PubMed ID: 31369714
[TBL] [Abstract][Full Text] [Related]
10. Lysophosphatidic acid stimulates cell proliferation in rat chondrocytes.
Kim MK; Lee HY; Park KS; Shin EH; Jo SH; Yun J; Lee SW; Yoo YH; Lee YS; Baek SH; Bae YS
Biochem Pharmacol; 2005 Dec; 70(12):1764-71. PubMed ID: 16242672
[TBL] [Abstract][Full Text] [Related]
11. The atherogenic actions of LPC on vascular smooth muscle cells and its LPA receptor mediated mechanism.
Bao L; Qi J; Wang YW; Xi Q; Tserennadmid T; Zhao PF; Qi J; Damirin A
Biochem Biophys Res Commun; 2018 Sep; 503(3):1911-1918. PubMed ID: 30064908
[TBL] [Abstract][Full Text] [Related]
12. Lysophosphatidic acid as a mediator for proinflammatory agonists in a human corneal epithelial cell line.
Zhang Z; Liu Z; Meier KE
Am J Physiol Cell Physiol; 2006 Nov; 291(5):C1089-98. PubMed ID: 16760261
[TBL] [Abstract][Full Text] [Related]
13. LPA(4)/GPR23 is a lysophosphatidic acid (LPA) receptor utilizing G(s)-, G(q)/G(i)-mediated calcium signaling and G(12/13)-mediated Rho activation.
Lee CW; Rivera R; Dubin AE; Chun J
J Biol Chem; 2007 Feb; 282(7):4310-4317. PubMed ID: 17166850
[TBL] [Abstract][Full Text] [Related]
14. Lysophosphatidic Acid Signaling Axis Mediates Ceramide 1-Phosphate-Induced Proliferation of C2C12 Myoblasts.
Bernacchioni C; Cencetti F; Ouro A; Bruno M; Gomez-Muñoz A; Donati C; Bruni P
Int J Mol Sci; 2018 Jan; 19(1):. PubMed ID: 29300303
[TBL] [Abstract][Full Text] [Related]
15. Lysophosphatidic acid-induced vascular neointimal formation in mouse carotid arteries is mediated by the matricellular protein CCN1/Cyr61.
Hao F; Zhang F; Wu DD; An D; Shi J; Li G; Xu X; Cui MZ
Am J Physiol Cell Physiol; 2016 Dec; 311(6):C975-C984. PubMed ID: 27760754
[TBL] [Abstract][Full Text] [Related]
16. Regulation of mitogen-activated protein kinase cascades by low density lipoprotein and lysophosphatidic acid.
Gouni-Berthold I; Seewald S; Hescheler J; Sachinidis A
Cell Physiol Biochem; 2004; 14(3):167-76. PubMed ID: 15107593
[TBL] [Abstract][Full Text] [Related]
17. Lysophosphatidic acid-induced membrane ruffling and brain-derived neurotrophic factor gene expression are mediated by ATP release in primary microglia.
Fujita R; Ma Y; Ueda H
J Neurochem; 2008 Oct; 107(1):152-60. PubMed ID: 18680554
[TBL] [Abstract][Full Text] [Related]
18. Reciprocal regulation of miR-23a and lysophosphatidic acid receptor signaling in cardiomyocyte hypertrophy.
Yang J; Nie Y; Wang F; Hou J; Cong X; Hu S; Chen X
Biochim Biophys Acta; 2013 Aug; 1831(8):1386-94. PubMed ID: 23711961
[TBL] [Abstract][Full Text] [Related]
19. Lysophosphatidic acid enhances human umbilical cord mesenchymal stem cell viability without differentiation via LPA receptor mediating manner.
Li N; Yan YL; Fu S; Li RJ; Zhao PF; Xu XY; Yang JP; Damirin A
Apoptosis; 2017 Oct; 22(10):1296-1309. PubMed ID: 28766061
[TBL] [Abstract][Full Text] [Related]
20. LPA
Wang F; Liu S; Pei J; Cai L; Liu N; Liang T; Dong X; Cong X; Chun J; Chen J; Hu S; Chen X
Theranostics; 2020; 10(24):10892-10907. PubMed ID: 33042260
[No Abstract] [Full Text] [Related]
[Next] [New Search]
